Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01003262 · ClinicalTrials.gov registry record · NA

Evaluating an Emergency Department Observation Syncope Protocol for Older Adults

A NA study of Syncope, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
123
Enrollment target
4
Study locations

NCT01003262 is a NA study of Syncope that has completed, run by University of California, Los Angeles. The registered enrollment target is 123 participants, below the 840-participant average among 11 other Syncope trials with a reported enrollment target (85% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01003262, a NA study of Syncope, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
123 participants
Enrollment target
4
Study locations

Study Summary

Syncope, defined as a transient loss of consciousness, accounts for over 700,000 annual U.S. emergency department visits and may herald a life-threatening condition in older adults (age≥60 years). Existing risk prediction instruments cannot reliably identify who among such older patients can safely be discharged home from an emergency department. As a result, the majority of older patients without a clear cause for syncope are hospitalized for diagnostic evaluation. However, current admission practices are characterized by low diagnostic yield, do not clearly improve outcomes, and account for over $2.4 billion in annual hospital costs. Most admitted patients are discharged within 48 hours, and approximately 50% of patients do not have an identified cause of syncope after their hospitalization. The implementation of an expedited and standardized Emergency Department Observation Syncope Protocol (EDOSP) may safely reduce hospitalization of older patients with syncope. The investigators propose a pilot randomized trial to implement and evaluate EDOSP at two emergency departments. This study has the following exploratory Specific Aims: 1. To compare admission rates and length-of-stay associated with EDOSP to standard care. 2. To compare serious outcomes rates associated with EDOSP to standard care. 3. To compare quality-of-life associated with EDOSP to standard care. 4. To compare the incremental costs and cost-effectiveness of EDOSP to standard care. Over a one-year period, 120 intermediate-risk older adults who present with syncope at the two study sites will be randomized to 1 of 2 arms: 1.) intervention arm: expedited and standardized EDOSP care; or 2.) control arm: routine care consisting of admission from the emergency department. If this pilot trial suggests that EDOSP can safely reduce admissions, then the investigators will plan a larger study powered to evaluate clinical, quality-of-life, and economic outcomes. A successful EDOSP intervention would have im

Conditions Studied

Interventions

  • OTHER Emergency Department Observation Protocol
  • OTHER Unstructured, inpatient evaluation

Study Locations (4)

California

  • University of Southern California - Los Angeles

Massachusetts

  • Brigham and Women's Hospital - Boston

Michigan

  • William Beaumont Hospital - Royal Oaks

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 123 participants
Start Date 2010-03
Est. Completion 2011-12
Phase NA

What the Registry Record Tells You About NCT01003262

The ClinicalTrials.gov registry entry for NCT01003262 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 840-participant average among 11 other Syncope trials with a reported enrollment target (85% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Syncope appearing as the primary indexed condition, and to 2 interventions - of which Emergency Department Observation Protocol is the first listed.

NCT01003262 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Massachusetts, Michigan.

Frequently Asked Questions

What is clinical trial NCT01003262 about?

NCT01003262 is a clinical study titled "Evaluating an Emergency Department Observation Syncope Protocol for Older Adults". Syncope, defined as a transient loss of consciousness, accounts for over 700,000 annual U.S. emergency department visits and may herald a life-threatening condition in older adults (age≥60 years). Existing risk prediction instruments cannot reliably identify who among such older patients can safely ...

What is the current status of trial NCT01003262?

This trial is currently completed. It is a NA study. The enrollment target is 123 participants. The study started on 2010-03. Estimated completion is 2011-12.

What conditions does trial NCT01003262 study?

This clinical trial studies the following conditions: Syncope.

What interventions are being tested in trial NCT01003262?

The interventions under investigation include: Emergency Department Observation Protocol (OTHER), Unstructured, inpatient evaluation (OTHER).

Who is sponsoring clinical trial NCT01003262?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01003262 being conducted?

This trial has 4 study locations across California, Massachusetts, Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Syncope

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.